Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link. All three major indices are trading up today with the Dow Jones Industrial Average ( ^DJI) trading up 52 points (0.3%) at 15,523 as of Thursday, Aug. 8, 2013, 12:45 PM ET. The NYSE advances/declines ratio sits at 1,945 issues advancing vs. 956 declining with 122 unchanged. The Real Estate industry currently sits up 0.4% versus the S&P 500, which is up 0.4%. On the negative front, top decliners within the industry include Walker & Dunlop ( WD), down 12.4%, Brookfield Residential Properties ( BRP), down 3.2%, Strategic Hotels & Resorts ( BEE), down 2.6%, Prologis ( PLD), down 0.9% and Weyerhaeuser ( WY), down 0.9%. Top gainers within the industry include Redwood ( RWT), up 11.2%, CommonWealth REIT ( CWH), up 6.1%, Howard Hughes ( HHC), up 2.8% and Vornado Realty ( VNO), up 1.1%. TheStreet would like to highlight 5 stocks pushing the industry lower today: 5. Medical Properties ( MPW) is one of the companies pushing the Real Estate industry lower today. As of noon trading, Medical Properties is down $0.45 (-3.2%) to $13.63 on average volume. Thus far, 643,010 shares of Medical Properties exchanged hands as compared to its average daily volume of 1.3 million shares. The stock has ranged in price between $13.53-$14.20 after having opened the day at $14.10 as compared to the previous trading day's close of $14.08. Medical Properties Trust, Inc. operates as a real estate investment trust (REIT) in the United States. It acquires, develops, and invests in healthcare facilities; and leases healthcare facilities to healthcare operating companies and healthcare providers. Medical Properties has a market cap of $2.1 billion and is part of the financial sector. Shares are up 17.7% year to date as of the close of trading on Wednesday. Currently there are 2 analysts that rate Medical Properties a buy, 2 analysts rate it a sell, and 4 rate it a hold. TheStreet Ratings rates Medical Properties as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, solid stock price performance, impressive record of earnings per share growth, compelling growth in net income and expanding profit margins. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. Get the full Medical Properties Ratings Report now. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.